Paul D. Burgess

Insider Reports History

Entity
Individual
Location
C/O Translate Bio, Inc., 29 Hartwell Avenue, Lexington, MA
Signature
/s/ Mark Bodenrader, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul D. Burgess:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cerevel Therapeutics Holdings, Inc. Chief Business Development and Strategic Operations Officer Common Stock 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Business Development and Strategic Operations Officer Restricted Stock Units 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Business Development and Strategic Operations Officer Stock Option (Right to Buy) 0 Aug 1, 2024 Direct
Translate Bio, Inc. Chief Operating Officer, CLO, Secretary Common Stock 0 $38.00 Sep 14, 2021 Direct
Translate Bio, Inc. Chief Operating Officer, CLO, Secretary Stock Option (right to buy) 0 Sep 14, 2021 Direct

Insider Reports Filed by Paul D. Burgess

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CERE Cerevel Therapeutics Holdings, Inc. Aug 1, 2024 3 $0 4 Aug 5, 2024 Chief Business Development and Strategic Operations Officer
CERE Cerevel Therapeutics Holdings, Inc. Jan 19, 2024 1 $0 4 Jan 23, 2024 Title: Chief Business Development and Strategic Operations Officer
CERE Cerevel Therapeutics Holdings, Inc. Dec 19, 2023 2 $0 4 Dec 21, 2023 Title: Chief Business Development and Strategic Operations Officer
CERE Cerevel Therapeutics Holdings, Inc. Aug 4, 2023 1 $502K 4 Aug 7, 2023 Chief Business Development and Strategic Operations Officer
CERE Cerevel Therapeutics Holdings, Inc. Jul 3, 2023 2 $0 4 Jul 6, 2023 Title: Chief Business Development and Strategic Operations Officer
CERE Cerevel Therapeutics Holdings, Inc. Jun 20, 2023 0 $0 3 Jun 28, 2023 Title: Chief Business Development and Strategic Operations Officer. Exhibit 24 - Power of Attorney
TBIO Translate Bio, Inc. Sep 14, 2021 6 -$2.73M 4 Sep 14, 2021 Chief Operating Officer, CLO, Secretary